IGFBP2, having been widely accepted as one of the estrogen-responsive genes, appears to be involved in the maintenance of ERα and is regulated by E2 administration in ERα-positive breast carcinoma cell lines [34], rat hippocampus [35] and adult articular cartilage [36]. The gene discussed is IGFBP2; the disease is breast carcinoma.